(Q53509282)

English

Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.

scientific article published on 11 May 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

M W Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

Y J Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

S W Park

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

J H Hwang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

S I Jung

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

H J Jeon

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

W K Kwon

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

language of work or name

0 references

publication date

11 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

British Journal of Radiology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

82

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

983

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

908-915

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Image-guided tumor ablation: standardization of terminology and reporting criteria

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Percutaneous radiofrequency ablation of liver dome hepatocellular carcinoma invisible on ultrasonography: a new targeting strategy.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Hepatic radiofrequency under CT-fluoroscopy guidance.

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F55877882

21 January 2018

Identifiers

10.1259/BJR/55877882

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

release_3gzvmnocfbcjdngew2pfdzzr2a

1 reference

https://api.fatcat.wiki/v0/release/3gzvmnocfbcjdngew2pfdzzr2a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/19433482

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53509282&oldid=1839174447"